Skip to content

Effects of Hookah (Waterpipe) Smoking on Blood Vessel Function

Effects of Hookah Smoking on Vascular Regulation: Novel Insight Into Endothelial Function

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03616002
Enrollment
58
Registered
2018-08-06
Start date
2015-01-01
Completion date
2020-03-31
Last updated
2021-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hookah Smoking

Brief summary

The purpose of this study is to assess the acute effects of Hookah (waterpipe) smoking on blood vessel function. Hookah smoking has been shown to immediately increase blood pressure and heart rate which could result in damage in the inner lining of the body's blood vessels.

Detailed description

The investigators will measure acute endothelial and vascular changes before and after a 30-minute Hookah smoking session in a controlled laboratory environment to: (1) Determine the acute effects of Hookah smoking on large-vessel endothelial vasodilator function measured by brachial artery flow mediated dilation; (2) Determine the acute effects of Hookah smoking on micro-vessel endothelial function as measured by reactive hyperemia peripheral arterial tonometry; (3) Determine the acute effects of Hookah smoking on pulse wave velocity and aortic pressure waveform measured by pulse tonometry.

Interventions

ad lib hookah smoking for 30 minutes in a controlled laboratory environment.

Sponsors

University of California, Los Angeles
CollaboratorOTHER
University of California, San Francisco
CollaboratorOTHER
Cedars-Sinai Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 29 Years
Healthy volunteers
Yes

Inclusion criteria

* 18 to 29 years of age * Habitual Hookah smoker defined as having smoked Hookah \>=12 times in the past 12 months * Have not smoked cigarettes within the past 12 months

Exclusion criteria

* History of cardiopulmonary, diabetes, dyslipidemia or psychiatric disease * Exhaled carbon monoxide level \>10 ppm * BP \< 140/90 mmHg * BMI \<18.5 or \> 30 kg•m2 * Resting heart rate \> 100 beats/min * Taking prescription medication * History of illicit drug use * Pregnant

Design outcomes

Primary

MeasureTime frame
Brachial artery flow-mediated dilationchange from baseline to immediately after smoking

Secondary

MeasureTime frame
Reactive hyperemia peripheral arterial tonometrychange from baseline to immediately after smoking

Other

MeasureTime frame
Pulse wave velocitychange from baseline to immediately after smoking
aortic pressure waveformchange from baseline to immediately after smoking

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026